Antithrombotic therapy in atrial fibrillation: aspirin is rarely the right choice

Atrial fibrillation, the commonest cardiac arrhythmia, predisposes to thrombus formation and consequently increases risk of ischaemic stroke. Recent years have seen approval of a number of novel oral anticoagulants. Nevertheless, warfarin and aspirin remain the mainstays of therapy. It is widely app...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabir, Ian N, Matthews, Gareth D K, Huang, Christopher L-H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3664370/
https://www.ncbi.nlm.nih.gov/pubmed/23404744
http://dx.doi.org/10.1136/postgradmedj-2012-131386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3664370/
https://www.ncbi.nlm.nih.gov/pubmed/23404744
http://dx.doi.org/10.1136/postgradmedj-2012-131386

Ejemplares similares